{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:56:56Z","timestamp":1785527816766,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Changzhou City Social Development and Technology Support Project","award":["CE20235057"],"award-info":[{"award-number":["CE20235057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12138-6","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:10:11Z","timestamp":1785244211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["M2 macrophage-derived extracellular vesicles (EVs) miR-155-5p promotes pulmonary fibrosis via epithelial-mesenchymal transition in lung epithelial cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Shuhong","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkang","family":"Huangfu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"12138_CR1","doi-asserted-by":"publisher","first-page":"752316","DOI":"10.3389\/fmed.2021.752316","volume":"8","author":"JJ Gokey","year":"2021","unstructured":"Gokey JJ, Patel SD, Kropski JA (2021) The role of Hippo\/YAP signaling in alveolar repair and pulmonary fibrosis. Front Med (Lausanne) 8:752316","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"12138_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14336\/AD.2021.0730","volume":"13","author":"QY Yu","year":"2022","unstructured":"Yu QY, Tang XX (2022) Irreversibility of pulmonary fibrosis. Aging Dis 13(1):73\u201386","journal-title":"Aging Dis"},{"key":"12138_CR3","doi-asserted-by":"publisher","first-page":"115147","DOI":"10.1016\/j.addr.2023.115147","volume":"204","author":"R Diwan","year":"2024","unstructured":"Diwan R et al (2024) Emerging delivery approaches for targeted pulmonary fibrosis treatment. Adv Drug Deliv Rev 204:115147","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"12138_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM (2016) Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44(3):450\u2013462","journal-title":"Immunity"},{"key":"12138_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121747","author":"L Lis-Lopez","year":"2021","unstructured":"Lis-Lopez L et al (2021) Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomed 9(12):1747. https:\/\/doi.org\/10.3390\/biomedicines9121747","journal-title":"Biomedicines"},{"key":"12138_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2008","unstructured":"Martinez FO et al (2008) Macrophage activation and polarization. Front Biosci 13:453\u2013461","journal-title":"Front Biosci"},{"issue":"2","key":"12138_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J et al (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40(2):274\u2013288","journal-title":"Immunity"},{"issue":"17","key":"12138_CR8","doi-asserted-by":"publisher","first-page":"e88947","DOI":"10.1172\/jci.insight.88947","volume":"1","author":"LR Young","year":"2016","unstructured":"Young LR et al (2016) Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. JCI Insight 1(17):e88947","journal-title":"JCI Insight"},{"key":"12138_CR9","doi-asserted-by":"publisher","first-page":"105795","DOI":"10.1016\/j.intimp.2019.105795","volume":"75","author":"L Wang","year":"2019","unstructured":"Wang L et al (2019) Potential role of M2 macrophage polarization in ventilator-induced lung fibrosis. Int Immunopharmacol 75:105795","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"12138_CR10","doi-asserted-by":"publisher","first-page":"17876","DOI":"10.1038\/s41598-025-03113-5","volume":"15","author":"Y Xue","year":"2025","unstructured":"Xue Y et al (2025) Exosomes derived from M2 macrophage promote HUVECs proliferation, migration and tube formation in vitro. Sci Rep 15(1):17876","journal-title":"Sci Rep"},{"issue":"6","key":"12138_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420\u20131428","journal-title":"J Clin Invest"},{"issue":"9","key":"12138_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/stcltm\/szae052","volume":"13","author":"D Upadhya","year":"2024","unstructured":"Upadhya D, Shetty AK (2024) MISEV2023 provides an updated and key reference for researchers studying the basic biology and applications of extracellular vesicles. Stem Cells Transl Med 13(9):848\u2013850","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"12138_CR13","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 13(2):e12404","journal-title":"J Extracell Vesicles"},{"key":"12138_CR14","doi-asserted-by":"publisher","first-page":"587735","DOI":"10.2147\/IJN.S587735","volume":"21","author":"X Liu","year":"2026","unstructured":"Liu X, Yang Y, Ren L (2026) Polarization-specific macrophage-derived extracellular vesicles: molecular cargo, tumor microenvironment remodeling, and therapeutic opportunities. Int J Nanomed 21:587735","journal-title":"Int J Nanomed"},{"key":"12138_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.semcancer.2024.02.001","volume":"99","author":"Y Li","year":"2024","unstructured":"Li Y, Sui S, Goel A (2024) Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers. Semin Cancer Biol 99:5\u201323","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"12138_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12951-023-01921-3","volume":"21","author":"J Zhu","year":"2023","unstructured":"Zhu J et al (2023) Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases. J Nanobiotechnol 21(1):164","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"12138_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1186\/s12967-025-06810-x","volume":"23","author":"V Ganesh","year":"2025","unstructured":"Ganesh V et al (2025) Systematic review of extracellular vesicle-derived microRNAs involved in organ fibrosis: implications for arthrofibrosis therapy. J Transl Med 23(1):802","journal-title":"J Transl Med"},{"issue":"18","key":"12138_CR18","doi-asserted-by":"publisher","first-page":"8660","DOI":"10.7150\/thno.62820","volume":"11","author":"S Zhao","year":"2021","unstructured":"Zhao S et al (2021) Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics 11(18):8660\u20138673","journal-title":"Theranostics"},{"key":"12138_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1041327","volume":"13","author":"M Tepus","year":"2022","unstructured":"Tepus M, Tonoli E, Verderio EAM (2022) Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis. Front Pharmacol 13:1041327","journal-title":"Front Pharmacol"},{"issue":"3","key":"12138_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1152\/physrev.00032.2024","volume":"105","author":"KS Park","year":"2025","unstructured":"Park KS, L\u00e4sser C, L\u00f6tvall J (2025) Extracellular vesicles and the lung: from disease pathogenesis to biomarkers and treatments. Physiol Rev 105(3):1733\u20131821","journal-title":"Physiol Rev"},{"key":"12138_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101276","author":"S Li","year":"2022","unstructured":"Li S et al (2022) The emerging role of extracellular vesicles from mesenchymal stem cells and macrophages in pulmonary fibrosis: insights into miRNA delivery. Pharmaceuticals (Basel) 15(10):1276. https:\/\/doi.org\/10.3390\/ph15101276","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"12138_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-025-00444-y","volume":"22","author":"Y Ren","year":"2025","unstructured":"Ren Y et al (2025) Exosomes derived from M2 macrophages regulate airway inflammation by modulating epithelial cell proliferation and apoptosis. Journal of Inflammation 22(1):19","journal-title":"Journal of Inflammation"},{"key":"12138_CR23","doi-asserted-by":"crossref","unstructured":"Qun L et al (2023) Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2. Stem Cell Res Ther 14(1):234","DOI":"10.1186\/s13287-023-03449-7"},{"issue":"4","key":"12138_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2144\/000112729","volume":"44","author":"RH H\u00fcbner","year":"2008","unstructured":"H\u00fcbner RH et al (2008) Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44(4):507\u2013511","journal-title":"Biotechniques"},{"issue":"3","key":"12138_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/08923973.2022.2115923","volume":"45","author":"L Wu","year":"2023","unstructured":"Wu L, Pu L, Zhuang Z (2023) MiR-155-5p\/FOXO3a promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome activation. Immunopharmacol Immunotoxicol 45(3):257\u2013267","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"Suppl 1","key":"12138_CR26","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.3904\/kjim.2019.098","volume":"36","author":"X Sun","year":"2021","unstructured":"Sun X et al (2021) In vivo therapeutic success of MicroRNA-155 antagomir in a mouse model of pulmonary fibrosis induced by bleomycin. Korean J Intern Med 36(Suppl 1):S160\u2013S169","journal-title":"Korean J Intern Med"},{"key":"12138_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Front Immunol 5:614","journal-title":"Front Immunol"},{"issue":"10","key":"12138_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.imbio.2014.05.005","volume":"219","author":"R Mulder","year":"2014","unstructured":"Mulder R, Banete A, Basta S (2014) Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states. Immunobiology 219(10):737\u2013745","journal-title":"Immunobiology"},{"key":"12138_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194985","author":"S Usman","year":"2021","unstructured":"Usman S et al (2021) Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13194985","journal-title":"Cancers (Basel)"},{"issue":"Pt 19","key":"12138_CR30","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1242\/jcs.099697","volume":"125","author":"RY Huang","year":"2012","unstructured":"Huang RY, Guilford P, Thiery JP (2012) Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci 125(Pt 19):4417\u20134422","journal-title":"J Cell Sci"},{"key":"12138_CR31","doi-asserted-by":"publisher","first-page":"928933","DOI":"10.3389\/fphar.2022.928933","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Huang H, Li Y (2022) Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis. Front Pharmacol 13:928933","journal-title":"Front Pharmacol"},{"key":"12138_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41392-019-0080-7","volume":"4","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019) The roles of exosomal miRNAs and lncRNAs in lung diseases. Signal Transduct Target Ther 4:47","journal-title":"Signal Transduct Target Ther"},{"key":"12138_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.omtn.2023.07.012","volume":"33","author":"S Bala","year":"2023","unstructured":"Bala S et al (2023) Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling. Mol Ther Nucleic Acids 33:413\u2013427","journal-title":"Mol Ther Nucleic Acids"},{"key":"12138_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15070473","author":"KH Rhee","year":"2023","unstructured":"Rhee KH et al (2023) MiR-155-5p Elevated by Ochratoxin A Induces Intestinal Fibrosis and Epithelial-to-Mesenchymal Transition through TGF-\u03b2 Regulated Signaling Pathway In Vitro and In Vivo. Toxins (Basel) 15(7):473. https:\/\/doi.org\/10.3390\/toxins15070473","journal-title":"Toxins (Basel)"},{"key":"12138_CR35","doi-asserted-by":"crossref","unstructured":"Zhang W et al (2020) miR-155-5p Implicates in the pathogenesis of renal fibrosis via targeting SOCS1 and SOCS6. Oxid Med Cell Longev, 2020: p. 6263921","DOI":"10.1155\/2020\/6263921"},{"key":"12138_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gene.2018.01.049","volume":"653","author":"L Ren","year":"2018","unstructured":"Ren L et al (2018) MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B. Gene 653:43\u201350","journal-title":"Gene"},{"issue":"2","key":"12138_CR37","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1096\/fj.201902063R","volume":"34","author":"H Tang","year":"2020","unstructured":"Tang H et al (2020) SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis. FASEB J 34(2):2011\u20132023","journal-title":"FASEB J"},{"issue":"5","key":"12138_CR38","first-page":"3695","volume":"22","author":"N Yang","year":"2020","unstructured":"Yang N et al (2020) miR\u2013155\u20135p downregulation inhibits epithelial\u2013to\u2013mesenchymal transition by targeting SIRT1 in human nasal epithelial cells. Mol Med Rep 22(5):3695\u20133704","journal-title":"Mol Med Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12138-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:14:34Z","timestamp":1785521674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12138"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12138-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study has been approved by The First People\u2019s Hospital of Changzhou (Approval No. 2022-jiao-CL019).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1290"}}